Italy’s UniCredit and Spain’s Banco Santander are scrambling to save a plan that would create one of Europe’s largest money managers after the UK’s vote to leave the EU added to concerns about the outlook for the €5.3bn deal.
Pioneer Investments, UniCredit’s fund management arm, and Santander Asset Management have been in talks for more than 20 months to create a European fund manager with almost €400bn in assets.
The transaction has been hit by a number of complications since negotiations began, including new management at both banks and changes to the terms of the deal last year to avoid provoking US regulators.
One person close to the talks said that the UK’s vote to leave the EU has also changed the outlook for the deal. Investment companies based in London could face restrictions selling fund management products into the EU. European regulators are also scrutinising the deal.
Santander Asset Management has its headquarters in the City of London. A person following the negotiations closely said: “A lot has changed since the deal was first announced. The overall environment has evolved with a new CEO arriving at UniCredit and most recently Brexit.”
Full Content: Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas